Morgan Stanley
BSX icon

Morgan Stanley’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.18B Buy
20,263,664
+1,226,748
+6% +$132M 0.14% 129
2025
Q1
$1.92B Sell
19,036,916
-1,443,859
-7% -$146M 0.14% 137
2024
Q4
$1.83B Buy
20,480,775
+1,405,614
+7% +$126M 0.13% 137
2024
Q3
$1.6B Buy
19,075,161
+149,267
+0.8% +$12.5M 0.12% 159
2024
Q2
$1.46B Buy
18,925,894
+961,111
+5% +$74M 0.11% 167
2024
Q1
$1.23B Sell
17,964,783
-19,558,379
-52% -$1.34B 0.1% 197
2023
Q4
$2.17B Buy
37,523,162
+16,322,823
+77% +$944M 0.1% 197
2023
Q3
$1.12B Buy
21,200,339
+481,891
+2% +$25.4M 0.11% 164
2023
Q2
$1.12B Buy
20,718,448
+386,987
+2% +$20.9M 0.11% 177
2023
Q1
$1.02B Buy
20,331,461
+1,086,407
+6% +$54.4M 0.11% 185
2022
Q4
$890M Buy
19,245,054
+6,842,597
+55% +$317M 0.1% 201
2022
Q3
$480M Buy
12,402,457
+1,537,156
+14% +$59.5M 0.07% 284
2022
Q2
$405M Buy
10,865,301
+6,142,145
+130% +$229M 0.05% 349
2022
Q1
$209M Sell
4,723,156
-144,627
-3% -$6.41M 0.03% 511
2021
Q4
$207M Buy
4,867,783
+92,629
+2% +$3.93M 0.03% 553
2021
Q3
$207M Buy
4,775,154
+167,459
+4% +$7.27M 0.03% 516
2021
Q2
$197M Buy
4,607,695
+476,827
+12% +$20.4M 0.03% 550
2021
Q1
$160M Sell
4,130,868
-2,146,162
-34% -$82.9M 0.02% 563
2020
Q4
$226M Buy
6,277,030
+1,613,187
+35% +$58M 0.03% 433
2020
Q3
$178M Buy
4,663,843
+295,689
+7% +$11.3M 0.03% 422
2020
Q2
$153M Buy
4,368,154
+206,563
+5% +$7.25M 0.03% 425
2020
Q1
$136M Sell
4,161,591
-3,306,420
-44% -$108M 0.04% 414
2019
Q4
$338M Buy
7,468,011
+727,425
+11% +$32.9M 0.08% 241
2019
Q3
$274M Sell
6,740,586
-97,640
-1% -$3.97M 0.07% 269
2019
Q2
$294M Sell
6,838,226
-30,582
-0.4% -$1.31M 0.08% 253
2019
Q1
$264M Sell
6,868,808
-791,002
-10% -$30.4M 0.07% 276
2018
Q4
$271M Buy
7,659,810
+702,325
+10% +$24.8M 0.08% 250
2018
Q3
$268M Sell
6,957,485
-559,899
-7% -$21.6M 0.07% 288
2018
Q2
$246M Buy
7,517,384
+4,013,765
+115% +$131M 0.07% 291
2018
Q1
$95.7M Sell
3,503,619
-292,742
-8% -$8M 0.03% 610
2017
Q4
$94.1M Buy
3,796,361
+650,427
+21% +$16.1M 0.03% 618
2017
Q3
$91.8M Buy
3,145,934
+48,809
+2% +$1.42M 0.03% 602
2017
Q2
$85.9M Sell
3,097,125
-647,255
-17% -$17.9M 0.03% 626
2017
Q1
$93.1M Buy
3,744,380
+1,458,906
+64% +$36.3M 0.03% 598
2016
Q4
$49.4M Buy
2,285,474
+86,009
+4% +$1.86M 0.02% 884
2016
Q3
$52.4M Sell
2,199,465
-333,406
-13% -$7.94M 0.02% 827
2016
Q2
$59.2M Buy
2,532,871
+923,375
+57% +$21.6M 0.02% 708
2016
Q1
$30.3M Sell
1,609,496
-310,258
-16% -$5.84M 0.01% 1051
2015
Q4
$35.4M Buy
1,919,754
+194,734
+11% +$3.59M 0.01% 1007
2015
Q3
$28.3M Sell
1,725,020
-819,948
-32% -$13.5M 0.01% 1134
2015
Q2
$45M Sell
2,544,968
-382,438
-13% -$6.77M 0.02% 928
2015
Q1
$52M Buy
2,927,406
+487,926
+20% +$8.66M 0.02% 838
2014
Q4
$32.3M Buy
2,439,480
+141,104
+6% +$1.87M 0.01% 1120
2014
Q3
$27.1M Sell
2,298,376
-240,755
-9% -$2.84M 0.01% 1203
2014
Q2
$32.4M Buy
2,539,131
+1,164,802
+85% +$14.9M 0.01% 1055
2014
Q1
$18.6M Sell
1,374,329
-1,385,388
-50% -$18.7M 0.01% 1433
2013
Q4
$33.2M Sell
2,759,717
-425,565
-13% -$5.12M 0.01% 975
2013
Q3
$37.4M Buy
3,185,282
+986,193
+45% +$11.6M 0.02% 818
2013
Q2
$20.4M Buy
+2,199,089
New +$20.4M 0.01% 1168